| Alana Lyng-hughes, MS, CCC-SLP | |
|
800 Kensington Ave, Suite 100, Missoula, MT 59801-5674 | |
| (406) 552-1480 | |
| Not Available |
| Full Name | Alana Lyng-hughes |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 800 Kensington Ave, Missoula, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093269516 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3136 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alana Lyng-hughes, MS, CCC-SLP 4665 Goodan Ln, Missoula, MT 59808-9009 Ph: (406) 531-8140 | Alana Lyng-hughes, MS, CCC-SLP 800 Kensington Ave, Suite 100, Missoula, MT 59801-5674 Ph: (406) 552-1480 |
News Archive
As food enters the intestine, it embarks on windy, lengthy journey. For most of the route, its surroundings don't appear to change much.
Competitive Technologies, Inc. announced today that it will hold a conference for the medical community on May 17, 2010, in Boston, Mass. at the Marriott Long Wharf Hotel from 9:00 a.m. to 3:30 p.m., to introduce CTT's Calmare® pain therapy to the medical community. Professor Giuseppe Marineo, MD, DSc., Researcher, Founding President of Delta Research and Development, Tor Vergata University of Rome, is the Italian inventor of the "Scrambler Therapy," the technology used in the Calmare medical device.
In a recently published study in the journal Genome Research, a team of scientists led by Dr. Shaying Zhao at the University of Georgia have developed a novel cross-species comparative genomics and oncology strategy for cancer driver gene discovery, using microarray technologies from Roche NimbleGen, that differs fundamentally from current approaches which focus on human cancers only.
A research team at the University of Alberta, Canada, led by Dr. Daniel Limonta, has described two novel molecules with broad antiviral properties that are effective against a range of virus types, including SARS-CoV-2.
› Verified 4 days ago
Margaret Gainer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 Sw Higgins Ave, Missoula, MT 59803 Phone: 406-552-1480 Fax: 406-258-0516 | |
Mrs. Jennifer Dawn Danielson, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2408 Duncan Drive, Missoula, MT 59802 Phone: 406-239-3969 | |
Sarah Ann Leech Berklovich, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2827 Fort Missoula Rd, Missoula, MT 59804 Phone: 406-327-4050 | |
Elizabeth Elgie, MS CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3335 Lt Moss Rd, Missoula, MT 59804 Phone: 406-549-6413 Fax: 406-542-0143 | |
Pediatric Speech Therapy Solutions, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4001 Melrose Pl, Missoula, MT 59808 Phone: 406-370-7342 Fax: 406-552-0150 | |
Kara Dobie, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 901 Sw Higgins Ave, Missoula, MT 59803 Phone: 406-552-1480 | |
Sarah Elliott, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2827 Fort Missoula Rd, Missoula, MT 59804 Phone: 406-728-4100 Fax: 406-327-4496 |